What Kairos Pharma Ltd's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Singhvi Rahul | Director | Oct 08 | Grant / award · A | +19,084 | — | — | 49,204 |
| Samuelson Doug | Chief Financial Officer | Oct 08 | Grant / award · A | +152,672 | — | — | 293,039 |
| Keyoung Hansoo Michael | Director | Oct 08 | Grant / award · A | +19,084 | — | — | 29,084 |
| Yu John S | CEO and Chairman | Oct 08 | Grant / award · A | +190,840 | — | — | 230,105 |
| Murali Ramachandran | VP of Research and Development | Oct 08 | Grant / award · A | +152,672 | — | — | 299,529 |
| Bhowmick Neil | Chief Scientific Officer | Oct 08 | Grant / award · A | +171,756 | — | — | 1,311,739 |
| Bae Hyun W. | Director | Oct 08 | Grant / award · A | +19,084 | — | — | 73,370 |
| Keyoung Hansoo Michael | Director | Sep 16 | Grant / award · A | +10,000 | — | — | 10,000 |
| Bae Hyun W. | Director | Sep 16 | Grant / award · A | +10,000 | — | — | 54,286 |
| Yu John S | CEO and Chairman | Jan 01 | Grant / award · A | +14,000 | — | — | 5,355,838 |
| Murali Ramachandran | VP of Research and Development | Jan 01 | Grant / award · A | +14,000 | — | — | 147,057 |
| Bhowmick Neil | Chief Scientific Officer | Jan 01 | Grant / award · A | +14,000 | — | — | 1,139,983 |
| Murali Ramachandran | VP of Research and Development | Nov 25 | Open-market buy · P | +200 | $1.59 | +$318 | 133,057 |
| Samuelson Doug | Chief Financial Officer | Nov 22 | Open-market buy · P | +2,500 | $1.50 | +$3.75K | 60,796 |
| Yu John S | CEO and Chairman | Nov 20 | Open-market buy · P | +4,000 | $1.44 | +$5.76K | 5,341,837 |
Loading...
